Codeine and morphine pathway
- 1 July 2009
- journal article
- pharmgkb summary
- Published by Ovid Technologies (Wolters Kluwer Health) in Pharmacogenetics and Genomics
- Vol. 19 (7), 556-558
- https://doi.org/10.1097/fpc.0b013e32832e0eac
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Pharmacogenetic insights into codeine analgesia: implications to pediatric codeine usePharmacogenomics, 2008
- Pharmacogenetics of Neonatal Opioid Toxicity Following Maternal Use of Codeine During Breastfeeding: A Case–Control StudyClinical Pharmacology & Therapeutics, 2008
- Pharmacogenetics of analgesics: toward the individualization of prescriptionPharmacogenomics, 2008
- Contribution of UDP-Glucuronosyltransferase 1A1 and 1A8 to Morphine-6-Glucuronidation and Its Kinetic PropertiesDrug Metabolism and Disposition, 2008
- Pharmacogenetics of OpioidsClinical Pharmacology & Therapeutics, 2007
- Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed motherThe Lancet, 2006
- Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers*Clinical Pharmacology & Therapeutics, 1996
- The Disposition of Morphine and Its 3- and 6-Glucuronide Metabolites in Humans and Animals, and the Importance of the Metabolites to the Pharmacological Effects of MorphineDrug Metabolism Reviews, 1996
- Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.British Journal of Clinical Pharmacology, 1991
- Disposition and metabolism of codeine after single and chronic doses in one poor and seven extensive metabolisers.British Journal of Clinical Pharmacology, 1991